Birdwatch Note Rating
2023-03-16 19:55:05 UTC - NOT_HELPFUL
Rated by Participant: 3DB9A9BFA8F7A17A52D354D21DF008C4029727F3E8F4E6B7CD1449831C73A204
Participant Details
Original Note:
From a GAO report on mifepristone: "FDA approved the drug under a provision of the agency’s Subpart H regulations … titled “Accelerated Approval of New Drugs". The regulation "provides FDA with flexibilities that allow the agency to accelerate the approval process" https://www.gao.gov/assets/gao-08-751.pdf
All Note Details